undamentalytics Newsletter
Sign in

Ideaya Biosciences, Inc. revenue

Ideaya Biosciences, Inc.'s revenue was $219m in fiscal 2025, up 3024.4% on the year before. Since fiscal 2020 ($19.5m) it has grown at a compound 62.1% a year. Over the last twelve months it was $234m.

Revenue history

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year2019Dec 20192020Dec 20202021Dec 20212022Dec 20222023Dec 20232024Dec 20242025Dec 2025LTMJun 2026
Revenue0202851237219234
Growth on the year before——+43.0%+82.3%−54.1%−70.1%+>999%—

Revenue as reported in the company's 10-K and 10-Q filings (for banks, net interest income plus non-interest income). Growth is left blank when the earlier figure was zero or negative.

Revenue against peers

Biotechnology: the closest covered companies by revenue. Last twelve months.

CompanyRevenueGrowth3-year growth a year
Ideaya Biosciences, Inc. $234m -70.1% 94.0%
Puma Biotechnology, Inc. $231m -2.9% 0.2%
Anaptysbio, Inc $238m 92.9% 163.9%
Rhythm Pharmaceuticals, Inc. $240m 53.5% 76.3%
Akebia Therapeutics, Inc. $219m 7.5% 2.9%
Ligand Pharmaceuticals Inc $254m 1.0% 18.2%

Compare with peers

Head to head: IDYA vs PBYIANAB vs IDYAIDYA vs RYTMAKBA vs IDYA

More: Biotechnology stocks compared, Health Care sector, rankings of US companies

Figures from Ideaya Biosciences, Inc.'s SEC filings (10-K and 10-Q), retrieved October 29, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Ideaya Biosciences, Inc.